[go: up one dir, main page]

BR9610214A - Compostos farmacéuticos - Google Patents

Compostos farmacéuticos

Info

Publication number
BR9610214A
BR9610214A BR9610214A BR9610214A BR9610214A BR 9610214 A BR9610214 A BR 9610214A BR 9610214 A BR9610214 A BR 9610214A BR 9610214 A BR9610214 A BR 9610214A BR 9610214 A BR9610214 A BR 9610214A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Application number
BR9610214A
Other languages
English (en)
Inventor
Richard E Moore
Vinod Francis Patel
James Edward Ray
John Eldon Toth
Original Assignee
Lilly Co Eli
Univ Hawaii
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Univ Hawaii, Univ Wayne State filed Critical Lilly Co Eli
Publication of BR9610214A publication Critical patent/BR9610214A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BR9610214A 1995-08-30 1996-08-30 Compostos farmacéuticos BR9610214A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US293595P 1995-08-30 1995-08-30
PCT/US1996/013855 WO1997007798A1 (en) 1995-08-30 1996-08-30 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
BR9610214A true BR9610214A (pt) 1999-06-15

Family

ID=21703268

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9610214A BR9610214A (pt) 1995-08-30 1996-08-30 Compostos farmacéuticos

Country Status (6)

Country Link
EP (2) EP0850316A4 (pt)
JP (2) JP2000501067A (pt)
AU (2) AU709828B2 (pt)
BR (1) BR9610214A (pt)
CA (2) CA2246117A1 (pt)
WO (2) WO1997007798A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000501067A (ja) * 1995-08-30 2000-02-02 イーライ・リリー・アンド・カンパニー 医薬化合物
ES2194129T3 (es) * 1995-12-22 2003-11-16 Univ Hawaii Compuestos farmaceuticos.
EA001913B1 (ru) * 1996-08-30 2001-10-22 Эли Лилли Энд Компани Фармацевтические соединения
WO1998008506A1 (en) * 1996-08-30 1998-03-05 Eli Lilly And Company Pharmaceutical compounds
US5977387A (en) * 1996-08-30 1999-11-02 Eli Lilly And Company Process for preparing pharmaceutical compounds
US6680311B1 (en) 1996-08-30 2004-01-20 Eli Lilly And Company Cryptophycin compounds
EP0929556A4 (en) * 1996-09-06 2001-04-18 Lilly Co Eli PROCESS AND NEW INTERMEDIATES
KR20000075671A (ko) * 1997-02-26 2000-12-26 피터 지. 스트링거 제약 화합물의 제조 방법
AU6338698A (en) * 1997-02-26 1998-09-18 Eli Lilly And Company Tripeptide and tetrapeptide pharmaceutical compounds
EP0870501A1 (en) * 1997-04-11 1998-10-14 Eli Lilly And Company Use of specific cryptophycin derivatives for the manufacture of a medicament in the treatment of fungal infections
EP0870506A1 (en) * 1997-04-11 1998-10-14 Eli Lilly And Company Compositions comprising a cryptophycin compound in combination with a synchronizing or activating agent for treating cancer
US6180679B1 (en) * 1998-04-07 2001-01-30 Eli Lilly And Company Method for treating fungal infections
US6376230B1 (en) 1998-10-16 2002-04-23 Eli Lilly And Company Stereoselective process for producing intermediates of cryptophycins
US6103913A (en) * 1998-10-16 2000-08-15 Eli Lilly And Company Process for preparing enollactone derivatives
EP2289549A3 (en) 1999-10-01 2011-06-15 Immunogen, Inc. Immunoconjugates for treating cancer
AU2002238939A1 (en) * 2002-03-18 2003-09-29 Nihon University Cyclic etheramine derivatives as medicaments for malignant tumors
US7229814B2 (en) 2004-05-05 2007-06-12 Regents Of The University Of Minnesota Nucleic acids and polypeptides involved in the production of cryptophycin
JPWO2007000994A1 (ja) * 2005-06-28 2009-01-22 中外製薬株式会社 抗ｈｃｖ作用を有する化合物の製造方法
CN103724290B (zh) * 2013-11-15 2015-04-29 浙江大学 一种环肽化合物clavatustide A及其产生菌、制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946835A (en) * 1988-07-15 1990-08-07 Merck & Co., Inc. Antifungal fermentation product and method
US4868208A (en) * 1988-07-15 1989-09-19 Merck & Co., Inc. Antifungal agent and method
US4845085A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US4845086A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US5952298A (en) * 1993-12-21 1999-09-14 The University Of Hawaii Cryptophycins
TJ347B (en) * 1995-03-07 2002-10-06 Univ Hawaii Cryptophicin compounds pharmacentical composition method to inhibit the proliteration of cells and and method to treat neoplasia
JP2000501067A (ja) * 1995-08-30 2000-02-02 イーライ・リリー・アンド・カンパニー 医薬化合物

Also Published As

Publication number Publication date
CA2246117A1 (en) 1997-03-06
AU709828B2 (en) 1999-09-09
AU7109096A (en) 1997-03-19
CA2230540A1 (en) 1997-03-06
WO1997007798A1 (en) 1997-03-06
EP0850057A4 (en) 2001-04-11
AU6904896A (en) 1997-03-19
EP0850057A1 (en) 1998-07-01
EP0850316A1 (en) 1998-07-01
JP2000507805A (ja) 2000-06-27
EP0850316A4 (en) 2000-08-23
JP2000501067A (ja) 2000-02-02
WO1997008334A1 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
FI970995L (fi) Farmaseuttisia yhdisteitä
FI971018L (fi) Farmaseuttisia yhdisteitä
FI973243L (fi) Uusi farmaseuttinen yhdistelmä
NO20004345D0 (no) Farmasøytisk sammensetning
ID16345A (id) Senyawa-senyawa heterosiklik
PT858325E (pt) Formulacao farmaceutica liofilizada estavel
FI973518A0 (fi) Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
IS4706A (is) Lyfjasamsetningar
BR9610153A (pt) Formulações farmacêuticas
BR9607097A (pt) Novos compostos
BR9600534A (pt) Novos compostos
NO981008D0 (no) Farmasöytisk formulering
FI954243A7 (fi) Farmaseuttiset yhdisteet
BR9610214A (pt) Compostos farmacéuticos
EE9800172A (et) Ühendid
BR9600809A (pt) Medicamento
BR9607626A (pt) Novos compostos farmacéuticos de naftila
LV11727A (lv) Farmaceitiska kompozicija
NO974170D0 (no) Polyazacykloalkan-forbindelser
FI973229A7 (fi) Uusi farmaseuttinen koostumus
FI973280A7 (fi) Farmaseuttinen koostumus
PT850048E (pt) Granulos farmaceuticos
FI973230A0 (fi) Uusi farmaseuttinen formulaatio
NO965448L (no) Farmasöytiske forbindelser
DE59610423D1 (de) Partikulare arzneiform

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
FA14 Dismissal: dismissal - article 34 of industrial property law
B11T Dismissal of application maintained [chapter 11.20 patent gazette]